Scalable Production of Lipid Nanoparticles Containing Amphotericin B-Reference-Cited by-同舟云学术

Scalable Production of Lipid Nanoparticles Containing Amphotericin B

Published:2021-06-08 Issue:24 Volume:37 Page:7312-7319
ISSN:0743-7463
Container-title:Langmuir
language:en
Short-container-title:Langmuir

Author:

Kulkarni Jayesh A.¹²^ORCID,Chen Sam³^ORCID,Tam Yuen Yi C.¹³

Affiliation:

1. Department of Biochemistry and Molecular Biology, University of British Columbia, 2350 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada

2. NanoVation Therapeutics, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3 Canada

3. Integrated Nanotherapeutics Inc., 205-4475 Wayburne Drive, Burnaby, British Columbia V5G 4X4, Canada

Funder

Canadian Institutes of Health Research

Networks of Centres of Excellence of Canada

Publisher

American Chemical Society (ACS)

Subject

Electrochemistry,Spectroscopy,Surfaces and Interfaces,Condensed Matter Physics,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.langmuir.1c00530

Reference34 articles.

1. Amphotericin B: 30 Years of Clinical Experience

2. Leishmania–Host-cell Interaction: Complexities and Alternative Views

3. Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven Aspergillosis

4. Amphotericin B colloidal dispersion: an improved antifungal therapy

5. Unusual lipid structures selectively reduce the toxicity of amphotericin B.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combatting Fungal Infections: Advances in Antifungal Polymeric Nanomaterials;Biomacromolecules;2024-08-23

2. Nanotechnology advancements in detecting pathogenic human RNA viruses;Recent Developments in Nanomaterial-based Sensing of Human Pathogens;2024

3. Morphological assessment of liposomes by microscopy;Liposomes in Drug Delivery;2024

4. Microfluidic Devices for Precision Nanoparticle Production;Micro;2023-10-31

5. Potential lipid-based strategies of amphotericin B designed for oral administration in clinical application;Drug Delivery;2023-01-05